Abstract
Several studies have shown increased in vitro cytokine responses to non-related pathogens after Bacillus Calmette-Guérin (BCG) vaccination. A total of 158 infants (80 BCG administered within 7 days of birth; 78 controls) were bled 4 days post-randomization, and at age 3 and 13 months. Geometric mean concentrations of IL-1β, TNF-α, IL-6 (24 h stimulation) and IFN-γ, IL-10, IL-17, IL-22 (96 h stimulation) in response to in vitro stimulation with RPMI, LPS, PHA, Escherichia coli, Streptococcus pneumoniae, Candida albicans and BCG were compared among BCG vaccinated children and controls. BCG vaccination did not affect in vitro cytokine production, except IFN-γ and IL-22 response to BCG. Stratifying for ‘age at randomization’ we found a potentiating effect of BCG on cytokine production (TNF-α, IL-6, IL-10) in the 4 days post randomization stimulations, among children who were vaccinated at age 2–7 days versus age 0–1 days. BCG vaccination did not potentiate cytokine production to non-BCG antigens. At 4 days post randomization, BCG was associated with higher cytokine production in the later randomized children.
Similar content being viewed by others
References
Ottenhoff THM, Kaufmann SHE (2012) Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8:e1002607. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3349743&tool=pmcentrez&rendertype=abstract. https://doi.org/10.1371/journal.ppat.1002607. Accessed 04 September 2017
Roy A, Eisenhut M, Harris RJ, Rodrigues LC (2014) Effect of BCG vaccination against mycobacterium tuberculosis infection in children: systematic review and meta-analysis. OPEN ACCESS 4643:1–11. https://doi.org/10.1136/bmj.g4643
Askeland EJ, Newton MR, O’Donnell MA , Luo Y (2012) Bladder cancer immunotherapy: BCG and beyond. Adv Urol 181987. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3388311&tool=pmcentrez&rendertype=abstract. https://doi.org/10.1155/2012/181987
Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, et al (2011) Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 204:245–52. http://jid.oxfordjournals.org/cgi/content/long/204/2/245. https://doi.org/10.1093/infdis/jir240
Biering-Sørensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, et al (2012) Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J 31:306–8. http://www.ncbi.nlm.nih.gov/pubmed/22189537. https://doi.org/10.1097/INF.0b013e3182458289
Higgins JPT, Soares-Weiser K, López-López JA, Kakourou A, Chaplin K, Christensen H, et al (2016) Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 13;i5170. http://www.bmj.com/lookup/doi/10.1136/bmj.i5170. https://doi.org/10.1136/bmj.i5170
Aaby P, Jensen H, Garly M-L, Balé C, Martins C, Lisse I (2002) Routine vaccinations and child survival in a war situation with high mortality: effect of gender. Vaccine 21:15–20. http://www.ncbi.nlm.nih.gov/pubmed/12443658
Kristensen I, Aaby P, Jensen H (2000) Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 321:1435–8. http://www.bmj.com/cgi/doi/10.1136/bmj.321.7274.1435. https://doi.org/10.1136/bmj.321.7274.1435
Roth A, Garly ML, Jensen H, Nielsen J, Aaby P (2006) Bacillus Calmette-Guérin vaccination and infant mortality. Expert Rev. Vaccines 5:277–93. http://www.ncbi.nlm.nih.gov/pubmed/16608427. https://doi.org/10.1586/14760584.5.2.277
Goodridge HS, Ahmed SS, Curtis N, Kollmann TR, Levy O, Netea MG, et al (2016) Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol 16:392–400. http://www.ncbi.nlm.nih.gov/pubmed/27157064%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4931283. https://doi.org/10.1038/nri.2016.43
Benn CS, Netea MG, Selin LK, Aaby P (2013) A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 34:431–9. http://www.ncbi.nlm.nih.gov/pubmed/23680130. https://doi.org/10.1016/j.it.2013.04.004
Kleinnijenhuis J, van Crevel R, Netea MG (2015) Trained immunity: consequences for the heterologous effects of BCG vaccination. Trans R Soc Trop Med Hyg 1;109:29–35. http://trstmh.oxfordjournals.org/cgi/doi/10.1093/trstmh/tru168. https://doi.org/10.1093/trstmh/tru168
Ritz N, Mui M, Balloch A, Curtis N (2013) Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations. Vaccine 2885–9. http://www.ncbi.nlm.nih.gov/pubmed/23583897. https://doi.org/10.1016/j.vaccine.2013.03.059
Ota MOC, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, Kidd M, et al (2002) Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 15:168:919–25. http://www.ncbi.nlm.nih.gov/pubmed/11777990
Nissen TN, Birk NM, Smits G, Jeppesen DL, Stensballe LG, Netea MG, et al (2017) Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial. Vaccine 35:2084–91. http://linkinghub.elsevier.com/retrieve/pii/S0264410X17302517. https://doi.org/10.1016/j.vaccine.2017.02.048
Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LAB, Jacobs C, et al (2014) Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 6:152–8. http://www.ncbi.nlm.nih.gov/pubmed/24192057. https://doi.org/10.1159/000355628
Jensen KJ, Larsen N, Biering-Sørensen S, Andersen A, Eriksen HB, Monteiro I et al (2015) Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial. J Infect Dis 211:956–67. http://jid.oxfordjournals.org/lookup/doi/10.1093/infdis/jiu508. https://doi.org/10.1093/infdis/jiu508
Kleinnijenhuis J, Quintin J, Preijers F, Joosten LAB, Ifrim DC, Saeed S, et al (2012) Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 109:17537–42. http://www.ncbi.nlm.nih.gov/pubmed/22988082. https://doi.org/10.1073/pnas.1202870109
Cheng S-C, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al (2014) mTOR- and HIF-1 -mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345:1250684–1250684. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4226238&tool=pmcentrez&rendertype=abstract. https://doi.org/10.1126/science.1250684
Netea MG, Joosten LAB, Latz E, Mills KHG, Natoli G, Stunnenberg HG et al (2016) Trained immunity: A program of innate immune memory in health and disease. Science 22;352:aaf1098. http://www.sciencemag.org/cgi/doi/10.1126/science.aaf1098. https://doi.org/10.1126/science.aaf1098
World Health Organization (2014) Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 –- conclusions and recommendations. Relev. épidémiologique Hebd. / Sect. d’hygiène du Secrétariat la Société des Nations = Wkly. Epidemiol. Rec. / Heal. Sect. Secr. Leag. Nations 89:221–36. http://www.who.int/wer/2014/wer8921.pdf?ua=1
Zwerling A, Behr M, Verma A, Brewer T, Menzies D, Pai M (2016) The World Atlas of BCG Policies and Practices. BCG. http://www.bcgatlas.org/
Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M (2011) The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med 8:e1001012. http://www.ncbi.nlm.nih.gov/pubmed/21445325. https://doi.org/10.1371/journal.pmed.1001012
Thøstesen LM, Nissen TN, Kjærgaard J, Pihl GT, Birk NM, Benn CS, et al (2015) Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial. Contemp Clin Trials 42:213–8. http://linkinghub.elsevier.com/retrieve/pii/S1551714415000774. https://doi.org/10.1016/j.cct.2015.04.006
Toukam Tchakoute C, Hesseling AC, Kidzeru EB, Gamieldien H, Passmore J-AS, Jones CE, et al (2014) Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T cell responses in HIV-exposed infants. J Infect Dis 211. http://www.ncbi.nlm.nih.gov/pubmed/25108027. https://doi.org/10.1093/infdis/jiu434
Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A, et al (2010) Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 185:2620–8. http://www.ncbi.nlm.nih.gov/pubmed/20644160. https://doi.org/10.4049/jimmunol.1000552
Lutwama F, Kagina BM, Wajja A, Waiswa F, Mansoor N, Kirimunda S et al (2014) Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis 209:887–897. https://doi.org/10.1093/infdis/jit570
Kjærgaard J, Birk NM, Nissen TN, Thøstesen LM, Pihl GT, Benn CS, et al (2016) Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial. Pediatr Res 80:1–5. http://www.ncbi.nlm.nih.gov/pubmed/27429204. https://doi.org/10.1038/pr.2016.142
Stensballe LG, Sørup S, Aaby P, Benn CS, Greisen G, Jeppesen DL, et al (2016) BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial. Arch Dis Child 310760. http://adc.bmj.com/lookup/doi/10.1136/archdischild-2016-310760. https://doi.org/10.1136/archdischild-2016-310760
Newhall KJ, Diemer GS, Leshinsky N, Kerkof K, Chute HT, Russell CB et al (2010) Evidence for endotoxin contamination in plastic Na+−heparin blood collection tube lots. Clin Chem 56:1483–1491. https://doi.org/10.1373/clinchem.2006.144618
Kollmann TR, Levy O, Montgomery RR, Goriely S (2012) Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 37:771–83. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3538030&tool=pmcentrez&rendertype=abstract. https://doi.org/10.1016/j.immuni.2012.10.014
Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S, Blitz R, et al (2009) Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. J Infect Dis 199:795–800. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3276835&tool=pmcentrez&rendertype=abstract
Weir RE, Gorak-Stolinska P, Floyd S, Lalor MK, Stenson S, Branson K, et al (2008) Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 8:9. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2263052&tool=pmcentrez&rendertype=abstract. https://doi.org/10.1186/1471–2334–8-9
Arts RJW, Blok BA, Aaby P, Joosten LAB, de Jong D, van der Meer JWM, et al (2015) Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity. J Leukoc Biol 98:995–1001. http://www.jleukbio.org/cgi/doi/10.1189/jlb.4MA0215-059R. https://doi.org/10.1189/jlb.4MA0215-059R
Smith SG, Kleinnijenhuis J, Netea MG, Dockrell HM (2017) Whole blood profiling of Bacillus Calmette–Guérin-induced trained innate immunity in infants identifies epidermal growth factor, IL-6, platelet-derived growth factor-AB/BB, and natural killer cell activation. Front Immunol 8:1–11. http://journal.frontiersin.org/article/10.3389/fimmu.2017.00644/full. https://doi.org/10.3389/fimmu.2017.00644
Biering-Sørensen S, Jensen KJ, Aamand SH, Blok B, Andersen A, Monteiro I, et al (2015) Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial. Vaccine 33:2056–65. https://doi.org/10.1016/j.vaccine.2015.02.056. https://doi.org/10.1016/j.vaccine.2015.02.056
Nissen TN, Birk NM, Kjærgaard J, Thøstesen LM, Pihl GT, Hoffmann T, et al (2016) Adverse reactions to the Bacillus Calmette–Guérin (BCG) vaccine in new-born infants—an evaluation of the Danish strain 1331 SSI in a randomized clinical trial. Vaccine 34:2477–82. http://www.sciencedirect.com/science/article/pii/S0264410X16300974. https://doi.org/10.1016/j.vaccine.2016.03.100
Kleinnijenhuis J, Quintin J, Preijers F, Joosten LAB, Jacobs C, Xavier RJ, et al (2014) BCG-induced trained immunity in NK cells: Role for non-specific protection to infection. Clin Immunol 155:213–9. http://linkinghub.elsevier.com/retrieve/pii/S1521661614002411. https://doi.org/10.1016/j.clim.2014.10.005
Kollmann TR (2015) BCG modulates neonatal innate immune cytokine production. J Infect Dis 211:859–860. https://doi.org/10.1093/infdis/jiu509
Ritz N, Dutta B, Donath S, Casalaz D, Connell TG, Tebruegge M, et al (2012) The influence of Bacille Calmette-Guérin vaccine strain on the immune response against tuberculosis. Am J Respir Crit Care Med 185:213–22. http://www.atsjournals.org/doi/abs/10.1164/rccm.201104-0714OC. https://doi.org/10.1164/rccm.201104-0714OC
Acknowledgements
Thanks to Monica Ladekarl for vaccinating most of the children; Linda Billetorp and Birgit Peitersen for examining and interviewing most of the participants; Vera Zingmark, Trine Mølbæk Jensen, Signe Kjeldgaard Jensen and Arild Ejsing for assisting the bleeding and lab work. We thank Heidi Lemmers and Helga Dijkstra for their help with the ELISAs. We thank the families and children for their participation, and The Danish Calmette Study staff for their commitment.
Funding
This work was supported by Copenhagen University Hospital, Hvidovre, and The Danish National Research Foundation (DNRF108). The funders did not have any role in the: study design, data collection, analysis and interpretation of data, writing the paper or in the decision to submit the article for publication.
Author information
Authors and Affiliations
Contributions
CB and MGN conceived the idea; TNN, MR, CB, OP and MGN designed the experiments. CB, PA, LGS, DLJ, PEK, TH, SN and OP supervised the collection of data in the overall Danish Calmette Study. JK and LMT participated in the overall data collection of The Danish Calmette Study. TNN and NMB collected the data for this sub-study. TNN and NBE initiated and managed the collection of biological samples of the cohort. BAB and RJWA participated and MGN supervised the ELISA analysis. TNN carried out data management, and analyzed the data with help from MGN, CB, MR, AA and OP. AA supervised the statistical analyses. TNN drafted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author), and all authors declare to have no potential conflict of interest. MGN was supported by an ERC Consolidator Grant (#310372) and a Spinoza grant of the Netherlands Organization for Scientific Research. MR receives funding from European Commission H2020 program [grant number TBVAC2020 643,381] and Research Council Norway [GLOBVAC 248042/H10].
Electronic supplementary material
Suppl. Figure 1
Dot plot of IFN-γ response to BCG stimulation in BCG vaccinated children and controls at 13 months. The dotted line displays the cut-off of 107 pg/ml and was defined as the value where 95% of the control children responded below. Of the BCG vaccinated children, 54% had IFN-γ response above the cut-off (GIF 4 kb)
ESM 1
(DOCX 14 kb)
Rights and permissions
About this article
Cite this article
Nissen, T.N., Birk, N.M., Blok, B.A. et al. Bacillus Calmette-Guérin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trial. Eur J Clin Microbiol Infect Dis 37, 29–41 (2018). https://doi.org/10.1007/s10096-017-3097-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-017-3097-2